🇺🇸 FDA
Patent

US 7951805

Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase

granted A61PA61P1/16A61P3/00

Quick answer

US patent 7951805 (Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase) held by Xenon Pharmaceuticals Inc. expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Xenon Pharmaceuticals Inc.
Grant date
Tue May 31 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61P, A61P1/16, A61P3/00, A61P3/04, A61P3/06